Townsend Richard Nolaninsider trades

In SEC Form 4 filings, Townsend Richard Nolan is listed as Chief Executive Officer of Lexeo Therapeutics, Inc. (LXEO). Townsend Richard Nolan reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 28.

Companies and roles

Company	Role	Transactions	Last filed
LXEOLexeo Therapeutics, Inc.	Chief Executive Officer	2	Sep 28

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-28

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
LXEOLexeo Therapeutics, Inc.	Sep 24	Sep 28	A · derivative	145,500	$3.39	$493,245	145,500	No	Form 4
LXEOLexeo Therapeutics, Inc.	Sep 14	Sep 28	A	2,306	$2.64	$6,097	376,778	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.